---
$id: https://graph.org.ai/products/commodity/51183601
$type: Product
source: UNSPSC
code: "51183601"
title: "Exenatide"
class: "51183600"
classTitle: "Antidiabetic and hyperglycemic peptide hormones"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Exenatide

**UNSPSC Code**: 51183601
**Class**: [Antidiabetic and hyperglycemic peptide hormones](Antidiabetic and hyperglycemic peptide hormones.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 9P1872D4OL. European Medicines Agency schedules Exenatide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21818. Exenatide generally arises in the molecular formula C184H282N50O60S. The term EXENATIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 18, no. 1, 2004, list 51.) Most nations, for tariff and trade purposes, schedule exenatide under HS 29332990 and SITC 51573. As of Q4 2014, EXENATIDE remains US FDA's Preferred Term for this commodity. Exenatide bears US NLM identifiers UMLS ID C0167117 and NCI Concept Code C65611. SMILES: NONE.

